Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Anaplastic Thyroid Cancer is a very aggressive disease. The investigators believe that
angiogenesis is very important for these tumors to progress. Preclinical data is suggesting
this. This is why we we prospectively want to treat these patients with avastin (and
doxorubicin). However, local control is of major concern. Therefore, patients are initially
treated with hyperfractionated radiotherapy and undergo surgery. Then they can enter this
study.